compact mass spectrometer
The test relies on a spermine risk score coupled with a urine test to predict which patients are most likely to have prostate cancer.
Agilent Q3 Revenues Up 6 Percent
The firm's diagnostics and genomics group saw an 11 percent year-over-year revenue increase in the third quarter.